Flow Therapy Adds World-Renowned Cardiologist Timothy D. Henry to Board of Directors
06 avr. 2022 09h00 HE
|
Flow Therapy
FORT WORTH, Texas, April 06, 2022 (GLOBE NEWSWIRE) -- World-renowned cardiologist Timothy D. Henry, MD, FACC, MSCAI, has joined Flow Therapy's Board of Directors. Dr. Henry is the Lindner Family...
Clearside Biomedical’s Suprachoroidal Injection Platform Featured at the Angiogenesis, Exudation, and Degeneration 2022 Virtual Conference
14 févr. 2022 16h05 HE
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the...
Mr. Daniel C. Montano, CEO, is recognized as Biotech Entrepreneur of the Year and Dr. Marc Kahn as Medical Professional of the Year by the Nevada Biotechnology & Health Science Consortium
17 juin 2021 13h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, June 17, 2021 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya” or the “Company”), is proud to announce that Mr. Daniel C. Montano, CEO, and founder of...
Worldwide 3D Cell Culture Industry to 2027 - Advantages of 3D Culture Techniques Over 2D Techniques is Driving Growth
09 févr. 2021 07h43 HE
|
Research and Markets
Dublin, Feb. 09, 2021 (GLOBE NEWSWIRE) -- The "3D Cell Culture Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to...
Multiple Sclerosis: Is Therapeutic Angiogenesis a Treatment or Even a Possible Cure?
18 nov. 2020 00h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (Zhittya), a private company, announced that it will give a Webinar broadcast on its potential breakthrough therapy to...
Zhittya Genesis Medicine Announces It Has Been Approved to Initiate Clinical Trials in Mexico for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
15 oct. 2020 10h30 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (Zhittya), a private company, announces that it will initiate clinical trials in Mexico to test a medical hypothesis that...
Zhittya Genesis Medicine Announces a Potential Major Medical Breakthrough for the Treatment of Parkinson’s Disease
22 sept. 2020 10h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (Zhittya), a private company, announces that it will initiate clinical trials to test a medical hypothesis that has been...
COVID-19 Lung Damage: Potential Breakthrough Drug Treatment Disclosed by Zhittya Genesis Medicine in Their Newly Released White Paper
17 juin 2020 10h30 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, June 17, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company)(“Zhittya” or the “Company”), announced that its latest White Paper, which details results on its...
Zhittya Genesis Medicine Releases Latest White Paper Highlighting its Potential Breakthrough Drug Treatment for Chronic Depression
19 févr. 2020 12h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya” or the “Company”), announced that its latest White Paper, which details results on its...
DiaMedica Therapeutics Announces First Quarter 2019 Financial Results and Provides Business Update
13 mai 2019 16h48 HE
|
DiaMedica Therapeutics Inc.
Phase Ib study of DM199 in Chronic Kidney Disease nearing full enrollmentCompletion of new cGMP manufacturing run of DM199Conference call with management tomorrow, May 14, 2019 at 7am CT MINNEAPOLIS,...